Russell Investments Group’s Akcea Therapeutics Inc AKCA Stock Holding History

Russell Investments Group’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-17,481	Closed	-$317K	–	3300
2020 Q3	$317K	Buy	+17,481	New	+$248K	﹤0.01%	2593
2020 Q2	–	Sell	-69,964	Closed	-$1M	–	3245
2020 Q1	$1M	Sell	69,964 -40,808	-37%	-$670K	﹤0.01%	1842
2019 Q4	$1.88M	Buy	110,772 +49,152	+80%	+$915K	﹤0.01%	1781
2019 Q3	$949K	Buy	+61,620	New	+$1.31M	﹤0.01%	2025

Russell Investments Group's AKCA Position: Q4 2020 in Review

Russell Investments Group sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 17,481 shares — an estimated $317K sold.

Russell Investments Group first reported a position in AKCA in Q3 2019 and held it in 4 quarters. The position peaked at $1.88M in Q4 2019. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Russell Investments Group reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Russell Investments Group sold 17,481 Akcea Therapeutics Inc shares in Q4 2020, an estimated $317K.
Russell Investments Group first reported a position in Akcea Therapeutics Inc in Q3 2019 and held it in 4 quarters.
Russell Investments Group's Akcea Therapeutics Inc position peaked at $1.88M in Q4 2019.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Russell Investments Group's 13F filing for Q4 2020, filed 8 Feb 2021.